Interventional Oncology Devices Market Report Examines Leading Companies And Growth Opportunities

The landscape of interventional oncology devices is evolving rapidly, driven by innovations and growing demand for more precise cancer treatments. As the medical community increasingly embraces minimally invasive procedures and advanced technologies, this sector is set to experience substantial growth in the coming years. Let's explore the market's anticipated size, key players, emerging trends, and detailed segmentation to better understand what lies ahead.

Interventional Oncology Devices Market Size Expected to Reach $3.5 Billion by 2030
The interventional oncology devices market is projected to expand significantly, reaching a value of $3.5 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 7.0%. Key factors contributing to this rise include a heightened demand for targeted cancer therapies, increased investments in precision oncology, a growing number of outpatient cancer treatment facilities, wider use of combination interventional therapies, and ongoing technological progress in ablation and embolization devices. Important market trends expected during the forecast period include greater use of image-guided tumor ablation devices, escalating adoption of minimally invasive cancer treatment methods, increased deployment of embolization therapies, expansion of precision oncology procedures, and improved integration of advanced imaging support systems.

Download a free sample of the interventional oncology devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Leading Companies Driving the Interventional Oncology Devices Market
Several prominent companies are shaping the interventional oncology devices market landscape. These include Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, AngioDynamics Inc., Viant Medical, Medtronic plc, Olympus Corporation, Koninklijke Philips, Quantum Surgical, Profound Medical, Intuitive Surgical Inc, Cook Medical LLC, EDAP TMS S.A, Varian Medical Systems Inc, Heraeus Medical, ABLbio, Bioavlee, Mediceena International, and LifeTech Scientific Corporation.
A notable development took place in May 2024 when Siemens Healthineers, a Germany-based supplier of devices and imaging systems for interventional oncology, formed a partnership with University Hospitals in the US. Their collaboration focuses on advancing precision care by innovating theranostics, introducing novel MR technologies, and enhancing integrated clinical solutions to improve outcomes in oncology, cardiovascular, and neurovascular treatments.

Emerging Technological Trends Enhancing Diagnostic and Treatment Precision
Key players in the interventional oncology devices market are increasingly investing in technologies that improve the accuracy of diagnostic and therapeutic procedures. One such innovation is focused on tissue volume, which refers to the amount of biological material collected during biopsy procedures. Collecting larger tissue samples leads to more accurate diagnoses and better-informed treatment planning.
For instance, in June 2023, Argon Medical, a US-based medical device company, launched the SuperCore Advantage semi-automatic biopsy device. This new product can harvest up to 35% more tissue samples compared to leading competitors, minimizing the number of biopsies needed and ensuring sufficient samples for accurate diagnosis.

View the full interventional oncology devices market report:
https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Detailed Market Segmentation of Interventional Oncology Devices
This report segments the interventional oncology devices market according to three major categories:
1) Product Types: Embolization Devices, Ablation Devices, Support Devices
2) Procedure Types: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), and Bland Embolization
3) Cancer Types: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, and Other Cancer Types

Subcategories of products are further broken down as follows:
- Embolization Devices include Embolic Agents, Catheters for Embolization, and Delivery Systems for Embolic Agents
- Ablation Devices encompass Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, and Laser Ablation Devices
- Support Devices cover Imaging Guidance Systems, Access Devices, and Fluid Management Systems

This comprehensive segmentation provides a clear view of the diverse components within the interventional oncology devices market and highlights where innovation and growth are concentrated.

New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.